MedTrace Logo

Breast Cancer in Pregnancy Register Study

NCT00196833 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2024-04-17

No results posted yet for this study

Summary

Women who were diagnosed with breast cancer during their pregnancy may be registered in this trial.

Data is collected on the foetal outcome 4 weeks after delivery, maternal outcome of pregnancy as well as the breast cancer therapy applied (treatment, response to chemotherapy, type of surgery), diagnostic procedures applied (palpation, US, mammogram) and the outcome of mother and child after 5 years of therapy.

Conditions

Sponsors & Collaborators

  • Goethe University

    collaborator OTHER

  • GBG Forschungs GmbH

    lead OTHER

Principal Investigators

  • Sibylle Loibl, Prof. Dr. · GBG Forschungs GmbH

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Primary Completion
2025-04-30
Completion
2026-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00196833 on ClinicalTrials.gov